Dian Diagnostics Group Co.,Ltd. (SHE:300244)
China flag China · Delayed Price · Currency is CNY
18.36
-0.10 (-0.54%)
Sep 1, 2026, 3:04 PM CST

Dian Diagnostics Group Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
9,92610,08912,19613,40720,28113,079
Other Revenue
7.197.280.371.361.713.6
9,93310,09612,19613,40820,28213,083
Revenue Growth
-8.99%-17.22%-9.04%-33.89%55.03%22.85%
Cost of Revenue
7,0227,2618,8119,25612,8098,100
Gross Profit
2,9112,8353,3854,1527,4734,983
Selling, General & Admin
1,7721,8502,0492,3002,8342,296
Research & Development
239.45254.54305.88432.64638.47424.75
Other Operating Expenses
20.1439.9639.3630.4456.1744.65
Operating Expenses
2,0042,3412,8393,1393,8172,856
Operating Income
907494.28546.341,0133,6572,127
Interest Expense
-84.73-161.46-203.03-250.6-274.73-230.2
Interest & Investment Income
27.8350.5464.3841.7669.6277.47
Currency Exchange Gain (Loss)
-3.71-4.8-2.020.84-25.12-2.33
Other Non Operating Income (Expenses)
-119.86-12.28-51.33-24.48-38.46-15.49
EBT Excluding Unusual Items
726.53366.28354.35780.653,3881,956
Impairment of Goodwill
-83.96-83.96-377.97--589.64-
Gain (Loss) on Sale of Investments
-7.773.53-28.72-18.32-56.24-187.72
Gain (Loss) on Sale of Assets
-2.04-0.18-1.48-3.57-11.186.35
Asset Writedown
-16.31-15.62-13.14-25.72-242.16-21.53
Legal Settlements
------7.59
Other Unusual Items
-35.99-13.8515.1365.2954.7445.1
Pretax Income
580.46256.19-51.83798.332,5441,791
Income Tax Expense
196.33110.58117.41216.74681.09307.4
Earnings From Continuing Operations
384.13145.61-169.23581.591,8621,484
Minority Interest in Earnings
-118-101.55-188.04-274.13-428.28-320.72
Net Income
266.1344.05-357.28307.461,4341,163
Net Income to Common
266.1344.05-357.28307.461,4341,163
Net Income Growth
----78.56%23.33%44.83%
Shares Outstanding (Basic)
611611617625623620
Shares Outstanding (Diluted)
611611617625624624
Shares Change
-0.18%-0.98%-1.30%0.18%-0.02%0.43%
EPS (Basic)
0.440.07-0.580.492.301.87
EPS (Diluted)
0.440.07-0.580.492.301.86
EPS Growth
----78.60%23.36%44.21%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
1,7571,743844.21,220691.64728.42
Free Cash Flow Per Share
2.882.851.371.951.111.17
Dividend Per Share
0.3500.3500.9000.0600.2000.135
Dividend Growth
40.00%-61.11%1400.00%-70.00%48.15%3.85%
Gross Margin
29.30%28.08%27.75%30.97%36.85%38.09%
Operating Margin
9.13%4.90%4.48%7.56%18.03%16.26%
Profit Margin
2.68%0.44%-2.93%2.29%7.07%8.89%
Free Cash Flow Margin
17.69%17.26%6.92%9.10%3.41%5.57%
EBITDA
1,183779.77942.661,4674,2472,468
EBITDA Margin
11.91%7.72%7.73%10.94%20.94%18.87%
D&A For EBITDA
275.54285.5396.32453.51590.21341.57
EBIT
907494.28546.341,0133,6572,127
EBIT Margin
9.13%4.90%4.48%7.56%18.03%16.26%
Effective Tax Rate
33.82%43.16%-27.15%26.78%17.16%
Revenue as Reported
5,16010,09612,19613,40820,28213,083
Advertising Expenses
-50.1459.2768.3476.5959.74